Log in

Advanz Pharma Earnings Date, Estimates & History (OTCMKTS:CXRXF)

$4.70
+0.31 (+7.06 %)
(As of 12/15/2019 09:31 AM ET)
Add
Compare
Today's Range
$3.98
Now: $4.70▼
$4.70
50-Day Range
$4.39
MA: $10.11▼
$12.02
52-Week Range
$3.98
Now: $4.70▼
$19.79
Volume6,531 shs
Average Volume1,016 shs
Market Capitalization$229.88 million
P/E RatioN/A
Dividend YieldN/A
Beta0.54

Earnings

Advanz Pharma (OTCMKTS:CXRXF) Earnings Information

Advanz Pharma last posted its earnings data on November 7th, 2019. The reported ($0.22) EPS for the quarter. The company had revenue of $119.64 million for the quarter. Advanz Pharma has generated $0.00 earnings per share over the last year. Advanz Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 12th, 2020 based off prior year's report dates.

Advanz Pharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Advanz Pharma (OTCMKTS CXRXF) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/12/2020
(Estimated)		       
11/7/2019Q3 2019($0.22)$2.00$119.64 millionN/A
8/7/2019Q2 2019($0.45)($0.42)$0.06$127.00 million$131.08 millionN/A
5/10/2019Q1 2019($0.16)($0.16)$135.64 millionN/A
3/14/2019Q4 2018($1.74)($1.74)$117.57 millionN/A
11/14/2018Q3 2018($0.03)($1.21)($150.18)$127.29 million$127.66 millionN/A
8/8/2018Q2 2018($0.07)($0.45)$2.54$139.49 millionN/A
5/15/2018Q1 2018($0.19)$0.71$152.26 millionN/A
3/8/2018Q4 2017$0.06($0.28)$7.86$150.21 millionN/A
11/14/2017Q3 2017$0.14$0.06$1.48$154.62 millionN/A
8/11/2017Q2 2017$0.15$0.19$20.16$160.79 millionN/A
5/10/2017Q1 2017($0.37)$0.80$160.56 millionN/A
3/15/2017Q4 2016$0.06$12.98$184.00 million$170.40 millionN/A
11/7/2016Q3 2016($0.33)$0.81$211.05 million$185.50 millionN/A
8/12/2016Q2 2016$1.48$1.21$13.60$240.41 million$231.71 millionN/A
5/13/2016Q1 2016$1.38$1.25$2.59$229.64 million$228.54 millionN/A
3/23/2016Q4 2015$1.32$1.08$2.80$182.23 million$191.91 millionN/A
11/12/2015Q3 2015$1.32$1.31$2.75$93.68 million$94.91 millionN/A
8/13/2015Q2 2015$1.02$0.96$1.94$78.60 million$77.51 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 12/15/2019 by MarketBeat.com Staff

Featured Article: How do analysts define an oversold condition?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel